{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:01:17Z","timestamp":1770512477859,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["U19 AI 096111"],"award-info":[{"award-number":["U19 AI 096111"]}]},{"name":"University of Washington Center for AIDS Research (CFAR)","award":["P30 AI 027757"],"award-info":[{"award-number":["P30 AI 027757"]}]},{"name":"Mary Gates Endowment for Students"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.antiviral.2015.12.007","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T11:05:33Z","timestamp":1450782333000},"page":"90-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy"],"prefix":"10.1016","volume":"126","author":[{"given":"Harshana S.","family":"De Silva Feelixge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1619-7541","authenticated-orcid":false,"given":"Daniel","family":"Stone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harlan L.","family":"Pietz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavitra","family":"Roychoudhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex L.","family":"Greninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua T.","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith R.","family":"Jerome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.antiviral.2015.12.007_bib1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/JVI.59.2.284-291.1986","article-title":"Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone","volume":"59","author":"Adachi","year":"1986","journal-title":"J.\u00a0Virol."},{"issue":"12","key":"10.1016\/j.antiviral.2015.12.007_bib2","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1371\/journal.ppat.0020127","article-title":"HIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANT","volume":"2","author":"Andersen","year":"2006","journal-title":"PLoS Pathog."},{"issue":"2","key":"10.1016\/j.antiviral.2015.12.007_bib3","doi-asserted-by":"crossref","first-page":"e16825","DOI":"10.1371\/journal.pone.0016825","article-title":"Successful targeting and disruption of an integrated reporter lentivirus using the engineered homing endonuclease Y2 I-AniI","volume":"6","author":"Aubert","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2015.12.007_bib4","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1038\/mtna.2013.75","article-title":"In\u00a0vitro inactivation of latent HSV by targeted mutagenesis using an HSV-specific homing endonuclease","volume":"3","author":"Aubert","year":"2014","journal-title":"Mol. Ther. Nucleic acids"},{"issue":"10","key":"10.1016\/j.antiviral.2015.12.007_bib5","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1038\/mt.2013.170","article-title":"Inactivation of hepatitis B virus replication in cultured cells and in\u00a0vivo with engineered transcription activator-like effector nucleases","volume":"21","author":"Bloom","year":"2013","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"1","key":"10.1016\/j.antiviral.2015.12.007_bib6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/165.1.105","article-title":"Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects","volume":"165","author":"Boucher","year":"1992","journal-title":"J.\u00a0Infect. Dis."},{"issue":"16","key":"10.1016\/j.antiviral.2015.12.007_bib7","doi-asserted-by":"crossref","first-page":"10718","DOI":"10.1128\/JVI.79.16.10718-10729.2005","article-title":"High sequence conservation of human immunodeficiency virus type 1 reverse transcriptase under drug pressure despite the continuous appearance of mutations","volume":"79","author":"Ceccherini-Silberstein","year":"2005","journal-title":"J.\u00a0Virol."},{"issue":"2","key":"10.1016\/j.antiviral.2015.12.007_bib8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/mt.2013.212","article-title":"An efficient antiviral strategy for targeting hepatitis B virus genome using transcription activator-like effector nucleases","volume":"22","author":"Chen","year":"2014","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"24","key":"10.1016\/j.antiviral.2015.12.007_bib9","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1158\/1078-0432.CCR-14-0250","article-title":"Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16\/18-positive cervical cancer cells","volume":"20","author":"Ding","year":"2014","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.antiviral.2015.12.007_bib10","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.antiviral.2015.12.007_bib11","doi-asserted-by":"crossref","first-page":"e0120047","DOI":"10.1371\/journal.pone.0120047","article-title":"A\u00a0high excision potential of TALENs for integrated DNA of HIV-based lentiviral vector","volume":"10","author":"Ebina","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.antiviral.2015.12.007_bib12","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/gt.2013.82","article-title":"Gene transfer of integration defective anti-HSV-1 meganuclease to human corneas ex\u00a0vivo","volume":"21","author":"Elbadawy","year":"2014","journal-title":"Gene Ther."},{"issue":"7","key":"10.1016\/j.antiviral.2015.12.007_bib13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.tibtech.2013.04.004","article-title":"ZFN, TALEN, and CRISPR\/Cas-based methods for genome engineering","volume":"31","author":"Gaj","year":"2013","journal-title":"Trends Biotechnol."},{"issue":"3\u20134","key":"10.1016\/j.antiviral.2015.12.007_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000360950","article-title":"Selected phenotypic assays used to evaluate antiviral resistance and viral fitness of hepatitis B virus and its variants","volume":"57","author":"Glebe","year":"2014","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.antiviral.2015.12.007_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5","volume":"36","author":"Graham","year":"1977","journal-title":"J.\u00a0Gen. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2015.12.007_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/mt.2010.302","article-title":"Meganuclease-mediated inhibition of HSV1 infection in cultured cells","volume":"19","author":"Grosse","year":"2011","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"issue":"8","key":"10.1016\/j.antiviral.2015.12.007_bib17","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1139\/g2012-049","article-title":"Homing endonucleases: DNA scissors on a mission","volume":"55","author":"Hafez","year":"2012","journal-title":"Genome\/National Res. Counc. Can.=Genome\/Conseil National de Recherches Canada"},{"issue":"5","key":"10.1016\/j.antiviral.2015.12.007_bib18","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/JVI.72.5.3773-3778.1998","article-title":"Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in\u00a0vitro","volume":"72","author":"Harrigan","year":"1998","journal-title":"J.\u00a0Virol."},{"issue":"1","key":"10.1016\/j.antiviral.2015.12.007_bib19","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1172\/JCI78206","article-title":"TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy","volume":"125","author":"Hu","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.antiviral.2015.12.007_bib20","doi-asserted-by":"crossref","first-page":"612823","DOI":"10.1155\/2014\/612823","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells","volume":"2014","author":"Hu","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"31","key":"10.1016\/j.antiviral.2015.12.007_bib21","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4 Suppl.\u00a03","key":"10.1016\/j.antiviral.2015.12.007_bib22","doi-asserted-by":"crossref","first-page":"19706","DOI":"10.7448\/IAS.17.4.19706","article-title":"Universal Tre (uTre) recombinase specifically targets the majority of HIV-1 isolates","volume":"17","author":"Karpinski","year":"2014","journal-title":"J.\u00a0Int. AIDS Soc."},{"issue":"Pt 2","key":"10.1016\/j.antiviral.2015.12.007_bib23","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1099\/0022-1317-75-2-341","article-title":"Zidovudine treatment results in the selection of human immunodeficiency virus type 1 variants whose genotypes confer increasing levels of drug resistance","volume":"75","author":"Kellam","year":"1994","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2015.12.007_bib24","first-page":"196","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476C","author":"Kennedy","year":"2014","journal-title":"Virology"},{"issue":"20","key":"10.1016\/j.antiviral.2015.12.007_bib25","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2015.12.007_bib26","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/ncomms7413","article-title":"Use of the CRISPR\/Cas9 system as an intracellular defense against HIV-1 infection in human cells","volume":"6","author":"Liao","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.antiviral.2015.12.007_bib27","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in\u00a0vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"2","key":"10.1016\/j.antiviral.2015.12.007_bib28","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.molcel.2008.06.016","article-title":"Rapid \u201copen-source\u201d engineering of customized zinc-finger nucleases for highly efficient gene modification","volume":"31","author":"Maeder","year":"2008","journal-title":"Mol. Cell"},{"issue":"11","key":"10.1016\/j.antiviral.2015.12.007_bib29","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.3390\/v5112748","article-title":"Newer gene editing technologies toward HIV gene therapy","volume":"5","author":"Manjunath","year":"2013","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.antiviral.2015.12.007_bib30","doi-asserted-by":"crossref","first-page":"e56633","DOI":"10.1371\/journal.pone.0056633","article-title":"Gene- and protein-delivered zinc finger-staphylococcal nuclease hybrid for inhibition of DNA replication of human papillomavirus","volume":"8","author":"Mino","year":"2013","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.antiviral.2015.12.007_bib31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s12033-014-9751-3","article-title":"Inhibition of DNA replication of human papillomavirus by using zinc finger-single-chain FokI Dimer hybrid","volume":"56","author":"Mino","year":"2014","journal-title":"Mol. Biotechnol."},{"issue":"4","key":"10.1016\/j.antiviral.2015.12.007_bib32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nsmb.2785","article-title":"Ty3 reverse transcriptase complexed with an RNA-DNA hybrid shows structural and functional asymmetry","volume":"21","author":"Nowak","year":"2014","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.antiviral.2015.12.007_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-801185-0.00003-9","article-title":"Determining the specificities of TALENs, Cas9, and other genome-editing enzymes","volume":"546","author":"Pattanayak","year":"2014","journal-title":"Methods Enzym."},{"issue":"5","key":"10.1016\/j.antiviral.2015.12.007_bib34","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"issue":"18","key":"10.1016\/j.antiviral.2015.12.007_bib35","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1097\/QAD.0000000000000494","article-title":"Global burden of transmitted HIV drug resistance and HIV-exposure categories: a systematic review and meta-analysis","volume":"28","author":"Pham","year":"2014","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.antiviral.2015.12.007_bib36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/rmv.1787","article-title":"Antiviral drug resistance in herpesviruses other than cytomegalovirus","volume":"24","author":"Piret","year":"2014","journal-title":"Rev. Med. Virol."},{"issue":"19","key":"10.1016\/j.antiviral.2015.12.007_bib37","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.1422340112","article-title":"Cas9-mediated targeting of viral RNA in eukaryotic cells","volume":"112","author":"Price","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"16","key":"10.1016\/j.antiviral.2015.12.007_bib38","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1093\/nar\/gkt571","article-title":"Zinc-finger-nucleases mediate specific and efficient excision of HIV-1 proviral DNA from infected and latently infected human T cells","volume":"41","author":"Qu","year":"2013","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.antiviral.2015.12.007_bib39","doi-asserted-by":"crossref","first-page":"5819","DOI":"10.1007\/s11033-014-3456-3","article-title":"Zinc finger nuclease: a new approach for excising HIV-1 proviral DNA from infected human T cells","volume":"41","author":"Qu","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.antiviral.2015.12.007_bib40","series-title":"Current Protocols in Molecular Biology","article-title":"Engineering designer nucleases with customized cleavage specificities","author":"Sander","year":"2011"},{"issue":"5833","key":"10.1016\/j.antiviral.2015.12.007_bib41","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1141453","article-title":"HIV-1 proviral DNA excision using an evolved recombinase","volume":"316","author":"Sarkar","year":"2007","journal-title":"Science"},{"issue":"307","key":"10.1016\/j.antiviral.2015.12.007_bib42","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aac5530","article-title":"Efficient modification of CCR5 in primary human hematopoietic cells using a megaTAL nuclease and AAV donor template","volume":"7","author":"Sather","year":"2015","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.antiviral.2015.12.007_bib43","doi-asserted-by":"crossref","first-page":"8920","DOI":"10.1128\/JVI.00052-12","article-title":"Targeted DNA mutagenesis for the cure of chronic viral infections","volume":"86","author":"Schiffer","year":"2012","journal-title":"J.\u00a0Virol."},{"issue":"7","key":"10.1016\/j.antiviral.2015.12.007_bib44","doi-asserted-by":"crossref","first-page":"e1003131","DOI":"10.1371\/journal.pcbi.1003131","article-title":"Predictors of hepatitis B cure using gene therapy to deliver DNA cleavage enzymes: a mathematical modeling approach","volume":"9","author":"Schiffer","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.antiviral.2015.12.007_bib45","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"3","key":"10.1016\/j.antiviral.2015.12.007_bib46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/COH.0b013e32835f736c","article-title":"Targeted gene disruption to cure HIV","volume":"8","author":"Stone","year":"2013","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"8","key":"10.1016\/j.antiviral.2015.12.007_bib47","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2013.46","article-title":"A\u00a0novel therapeutic molecule against HTLV-1 infection targeting provirus","volume":"27","author":"Tanaka","year":"2013","journal-title":"Leukemia"},{"issue":"36","key":"10.1016\/j.antiviral.2015.12.007_bib48","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","article-title":"RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2015.12.007_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.virol.2013.12.037","article-title":"DNA cleavage enzymes for treatment of persistent viral infections: recent advances and the pathway forward","volume":"454\u2013455","author":"Weber","year":"2014","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.antiviral.2015.12.007_bib50","doi-asserted-by":"crossref","first-page":"e97579","DOI":"10.1371\/journal.pone.0097579","article-title":"AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication","volume":"9","author":"Weber","year":"2014","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.antiviral.2015.12.007_bib51","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"Wei","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.antiviral.2015.12.007_bib52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.coi.2012.08.005","article-title":"Development of nuclease-mediated site-specific genome modification","volume":"24","author":"Wirt","year":"2012","journal-title":"Curr. Opin. Immunol."},{"issue":"0","key":"10.1016\/j.antiviral.2015.12.007_bib53","doi-asserted-by":"crossref","first-page":"e0136046","DOI":"10.1371\/journal.pone.0136046","article-title":"CRISPR\/Cas9 system as an agent for eliminating polyomavirus JC infection","volume":"10","author":"Wollebo","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2015.12.007_bib54","first-page":"37","article-title":"Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat\/Cas system in human cervical cancer cells","volume":"8","author":"Yu","year":"2015","journal-title":"OncoTargets Ther."},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2015.12.007_bib55","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1099\/jgv.0.000012","article-title":"CRISPR\/Cas9-mediated genome editing of Epstein-Barr virus in human cells","volume":"96","author":"Yuen","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"issue":"4","key":"10.1016\/j.antiviral.2015.12.007_bib56","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.bbrc.2014.07.014","article-title":"In\u00a0vitro and in\u00a0vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR\/Cas9","volume":"450","author":"Zhen","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.antiviral.2015.12.007_bib57","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.antiviral.2015.12.007_bib58","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12977-015-0150-z","article-title":"The CRISPR\/Cas9 system inactivates latent HIV-1 proviral DNA","volume":"12","author":"Zhu","year":"2015","journal-title":"Retrovirology"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354215300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,13]],"date-time":"2020-09-13T03:26:39Z","timestamp":1599967599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354215300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":58,"alternative-id":["S0166354215300462"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.12.007","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2015.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}